Matches in Wikidata for { <http://www.wikidata.org/entity/Q82617080> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q82617080 description "article scientifique publié en 2010" @default.
- Q82617080 description "artículu científicu espublizáu en payares de 2010" @default.
- Q82617080 description "im November 2010 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82617080 description "scientific article published on 25 November 2010" @default.
- Q82617080 description "wetenschappelijk artikel" @default.
- Q82617080 description "наукова стаття, опублікована в листопаді 2010" @default.
- Q82617080 name "Allergen-specific immunotherapy improves asthma symptoms compared with placebo, but the possibility of adverse effects should be considered" @default.
- Q82617080 name "Allergen-specific immunotherapy improves asthma symptoms compared with placebo, but the possibility of adverse effects should be considered" @default.
- Q82617080 type Item @default.
- Q82617080 label "Allergen-specific immunotherapy improves asthma symptoms compared with placebo, but the possibility of adverse effects should be considered" @default.
- Q82617080 label "Allergen-specific immunotherapy improves asthma symptoms compared with placebo, but the possibility of adverse effects should be considered" @default.
- Q82617080 prefLabel "Allergen-specific immunotherapy improves asthma symptoms compared with placebo, but the possibility of adverse effects should be considered" @default.
- Q82617080 prefLabel "Allergen-specific immunotherapy improves asthma symptoms compared with placebo, but the possibility of adverse effects should be considered" @default.
- Q82617080 P1433 Q82617080-C4041D94-5367-48EF-A5E7-07D469916D85 @default.
- Q82617080 P1476 Q82617080-7791FA81-6C16-49B5-9580-76B5E7E8F0B6 @default.
- Q82617080 P2093 Q82617080-91A848ED-0415-45C4-A2CC-6ED09A776C5E @default.
- Q82617080 P2093 Q82617080-AE2842A1-8EF1-4886-A2A0-E6C9B66B23CE @default.
- Q82617080 P304 Q82617080-2D04A7F6-27D1-44E4-904E-D13C1237ABA0 @default.
- Q82617080 P31 Q82617080-FF3D6C17-2B34-4A6C-A189-EC5CB9EE314D @default.
- Q82617080 P356 Q82617080-393263B0-6607-487B-978A-95313A181BC2 @default.
- Q82617080 P433 Q82617080-35FBCAA7-FACC-42C2-B266-BC8FA651FE89 @default.
- Q82617080 P478 Q82617080-874561DE-CD5F-4108-B66D-05270E803E97 @default.
- Q82617080 P577 Q82617080-D48984EC-A09B-48CB-8D23-2EC45209D29C @default.
- Q82617080 P698 Q82617080-194FFD83-7A21-44A5-B14C-BF582F5D4002 @default.
- Q82617080 P921 Q82617080-9FB4C8CF-394A-40A4-B0EC-E38E842B4394 @default.
- Q82617080 P921 Q82617080-C79C6FD0-A47B-4456-BAA5-24CAADCC4598 @default.
- Q82617080 P921 Q82617080-CDEEAC3E-3BFA-4B5A-9DD2-9E0A86976013 @default.
- Q82617080 P356 EBM1144 @default.
- Q82617080 P698 21109679 @default.
- Q82617080 P1433 Q26841868 @default.
- Q82617080 P1476 "Allergen-specific immunotherapy improves asthma symptoms compared with placebo, but the possibility of adverse effects should be considered" @default.
- Q82617080 P2093 "Anthony J Frew" @default.
- Q82617080 P2093 "Rabia Rashid" @default.
- Q82617080 P304 "16-17" @default.
- Q82617080 P31 Q13442814 @default.
- Q82617080 P356 "10.1136/EBM1144" @default.
- Q82617080 P433 "1" @default.
- Q82617080 P478 "16" @default.
- Q82617080 P577 "2010-11-25T00:00:00Z" @default.
- Q82617080 P698 "21109679" @default.
- Q82617080 P921 Q1427096 @default.
- Q82617080 P921 Q269829 @default.
- Q82617080 P921 Q35869 @default.